Relmada Therapeutics (RLMD) Interest & Investment Income (2014 - 2026)
Relmada Therapeutics (RLMD) reported Interest & Investment Income of $959762.0 for Q1 2026, up 117.99% year-over-year from $440287.0 in Q1 2025, and up 147.85% quarter-over-quarter from $387231.0 in Q4 2025.
Relmada Therapeutics (RLMD) Interest & Investment Income (2014 - 2026) Analysis & Trends
Relmada Therapeutics (RLMD) has 11 years of Interest & Investment Income data on file, last reported at $959762.0 in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $959762.0, up 117.99% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.9 million (down 34.28% YoY), and the FY2025 annual result was $1.4 million, down 60.45% from the prior year.
- Interest & Investment Income improved to $959762.0 in Q1 2026 per RLMD's latest filing, from $387231.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.4 million in Q2 2023 and troughed at $247013.0 in Q3 2025.
- A 4-year average of $849036.6 and a median of $959762.0 in 2026 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2025 and 2026: Interest & Investment Income plunged 71.16% in 2025, then jumped 117.99% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $1.3 million in 2023, then slumped by 48.01% to $654642.0 in 2024, then tumbled by 40.85% to $387231.0 in 2025, then soared by 147.85% to $959762.0 in 2026.
- Business Quant data shows RLMD's Interest & Investment Income at $959762.0 in Q1 2026, $387231.0 in Q4 2025, and $247013.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Relmada Therapeutics | 575.00 Mn | 575.00 Mn | - | 959,762.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 959,762.00 |
| Dec 31, 2025 | 387,231.00 |
| Sep 30, 2025 | 247,013.00 |
| Jun 30, 2025 | 321,458.00 |
| Mar 31, 2025 | 440,287.00 |
| Dec 31, 2024 | 654,642.00 |
| Sep 30, 2024 | 856,478.00 |
| Jun 30, 2024 | 963,013.00 |
| Mar 31, 2024 | 1.06 Mn |
| Dec 31, 2023 | 1.26 Mn |
| Sep 30, 2023 | 1.32 Mn |
| Jun 30, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.21 Mn |
| Sep 30, 2020 | 363,300.00 |
| Jun 30, 2020 | 404,004.00 |
| Sep 30, 2019 | 37,916.00 |
| Jun 30, 2019 | 13,110.00 |
| Mar 31, 2018 | -397,111.00 |
| Dec 31, 2017 | -311,871.00 |
| Sep 30, 2017 | 2,522.00 |